Evidence map›Paper›PMID 40045940›Full record

ReviewPHAGE (New Rochelle, N.Y.)2024

Beyond Antibiotics: Exploring the Potential of Bacteriophages and Phage Therapy.

Sudhangshu Kumar Biswas, Md Mehedi Hasan Sumon, Sabbir Ahmed, Rumana Akter Ruma, Anzana Parvin, Dipak Kumar Paul, Apurba Kumar Roy, Swee-Seong Tang

Abstract readReview
In one paragraph

Review in PHAGE (New Rochelle, N.Y.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Microbial Biotechnology in Medicine.Progress in molecular and subcellular biology · 2026
    Review
  3. Review
  4. Article
  5. Activity of BiocidinFrontiers in antibiotics · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sudhangshu Kumar BiswasBacteriophage Biology and Genomics Lab, Department of Biotechnology and Genetic Engineering, Faculty of Biological Sciences, Islamic University, Kushtia, Bangladesh.
Md Mehedi Hasan SumonBacteriophage Biology and Genomics Lab, Department of Biotechnology and Genetic Engineering, Faculty of Biological Sciences, Islamic University, Kushtia, Bangladesh.
Sabbir AhmedBacteriophage Biology and Genomics Lab, Department of Biotechnology and Genetic Engineering, Faculty of Biological Sciences, Islamic University, Kushtia, Bangladesh.
Rumana Akter RumaBacteriophage Biology and Genomics Lab, Department of Biotechnology and Genetic Engineering, Faculty of Biological Sciences, Islamic University, Kushtia, Bangladesh.
Anzana ParvinBacteriophage Biology and Genomics Lab, Department of Biotechnology and Genetic Engineering, Faculty of Biological Sciences, Islamic University, Kushtia, Bangladesh.
Dipak Kumar PaulDepartment of Applied Nutrition and Food Technology, Faculty of Biological Sciences, Islamic University, Kushtia, Bangladesh.
Apurba Kumar RoyDepartment of Genetic Engineering and Biotechnology, Faculty of Biological Sciences, University of Rajshahi, Rajshahi, Bangladesh.
Swee-Seong TangDivision of Microbiology, Institute of Biological Sciences, Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The escalating global threat of antibiotic resistance has prompted a critical need for innovative approaches to bacterial infection treatment. In terms of management, bacterial-associated disorders have reached a critical point in the world due to the advent of drug-resistant types of bacteria. Nonetheless, continued bacteriophage research presents a promising frontier in the battle against bacterial infections. In this study, we explored the effectiveness of bacteriophage therapy against antibiotic-resistant bacteria. According to our viewpoint, phage therapy could replace antibiotics in terms of safety, efficacy, and specificity. Furthermore, phage therapy offers versatility in administering single phage, phage products, or modified phage against various resistant bacteria. Moreover, Phage cocktails, with their synergistic combinations, showcase a holistic approach, mitigating the risk of resistance and expanding treatment possibilities. Similarly, the synergy between phages and antibiotics holds promise for overcoming antibiotic resistance and forging a path toward more effective and sustainable antimicrobial strategies. The review provides insights into the transformative impact of bacteriophage therapy on current bacterial infection treatment paradigms, its application with methodological challenges and limitations, as well as insights to scientists and policymakers on the best areas to study phages in order to combat antimicrobial resistance.

Indexed as

BacteriophageDrug resistantPhage engineeringPhage treatment

Identifiers

PMID40045940
PMCPMC11876823

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.